The link between opioid medication and pancreatic cancer

January 06, 2021

Researchers at Rush University Medical Center have found that opioid use might increase a person's risk of developing pancreatic cancer.

Published Jan. 6, the study, titled "Opioid Use as a Potential Risk Factor for Pancreatic Cancer in the United States," is the first in the country to show evidence that opioid use may be an unidentified risk factor contributing to the increasing incidence of pancreatic cancer.

In fact, opioid misuse and overdose have evolved into a public health crisis. Approximately 70,000 drug overdose deaths were reported in 2017, 68% of which involved an opioid.¹ The use of prescription opioids for the management of chronic pain has increased remarkably, with more than 191 million opioid prescriptions given to patients in the United States in 2017. Not surprisingly, the opioid addiction rates among patients who are given opioid for chronic pain have increased, with 29% of such patients misusing opioids, and 12% developing an opioid use disorder.²

Pancreatic cancer rates also are increasing in the United States. Opioids have been shown to have a harmful effect on multiple types of cancer with recent data suggesting opium use as a possible risk factor for pancreatic cancer in West Central Asia. Population-based studies have suggested opium use to increase risk of pancreatic cancer in a dose dependent manner.³?? While opium use is not a common recreational habit in the United States, opioid use has been rising remarkably over the past decade.

Faraz Bishehsari, MD, PhD, the corresponding author of the study, and his team aimed to examine the possible association between the pattern of opioid use and the changes in the rates of pancreatic cancer during the years 1999-2016. Using the Center for Disease Control's Wonder online data (procured from the Vital Statistics Cooperative Program) the team extracted the opioid death rate as a surrogate for prescription and illicit opioid use. Incidence of pancreatic cancer was retrieved from the CDC's online database gathered from the U.S. Cancer Statistics Working Group. They extracted the pattern of the lifestyle and behavioral factors that over time could potentially affect the risk of pancreatic cancer.

Usman Barlass, MD, Ameya Deshmukh, PhD, and Todd Beck, MD, worked with Bishehsari on the study. Using national datasets, the team evaluated whether the trend in opioid usage could explain increasing pancreatic cancer diagnoses at the national and state levels over time after correcting for the potential confounding factors. They found that both pancreatic cancer and opioid death rates rose over time at the national and state levels. A prior state's opioid death rate significantly predicted the trend in the incidence of pancreatic cancer years after and had a significant effect on the estimated annual change in the rate of this cancer.

The collected data suggests a link between opioid consumption and the risk of pancreatic cancer. The next step to directly establish the role of opioids as a novel risk factor for pancreatic cancer is to conduct large population-based studies or longitudinal datasets that reliably register long-term outcomes in opioid users. Findings from the current study, once confirmed by the individual-level data on opioid consumption and risk of pancreatic cancer, could have direct clinical relevance by considering non-narcotic (alternative) pain control approaches in these patients.

The team proposes to investigate possible mechanisms that may link opioid use to the development and/or progression of pancreatic cancer. Consistent with the current findings, a recent post hoc analysis of two randomized controlled trials of patients with advanced cancers (including pancreatic cancer), revealed that that those treated frequently with an opioid antagonist had significantly improved overall survival compared to placebo.?

"Our mechanistic studies could provide further insights on the pathways that opioid could potentially impact progression of cancer," Bishehsari added.
-end-
Citations

1. L. Scholl, P. Seth, M. Kariisa, N. Wilson, G. Baldwin, Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017, MMWR Morb Mortal Wkly Rep, 67 (2018) 1419-1427.

2. K.E. Vowles, M.L. McEntee, P.S. Julnes, T. Frohe, J.P. Ney, D.N. van der Goes, Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis, Pain, 156 (2015) 569-576.

3. S. Moossavi, M. Mohamadnejad, A. Pourshams, H. Poustchi, F. Islami, M. Sharafkhah, B. Mirminachi, S. Nasseri-Moghaddam, S. Semnani, R. Shakeri, A. Etemadi, S. Merat, M. Khoshnia, S.M. Dawsey, P.D. Pharoah, P. Brennan, C.C. Abnet, P. Boffetta, F. Kamangar, R. Malekzadeh, Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study, Cancer Epidemiol Biomarkers Prev, 27 (2018) 268-273.

4. R. Shakeri, F. Kamangar, M. Mohamadnejad, R. Tabrizi, F. Zamani, A. Mohamadkhani, S. Nikfam, A. Nikmanesh, M. Sotoudeh, R. Sotoudehmanesh, B. Shahbazkhani, M.R. Ostovaneh, F. Islami, H. Poustchi, P. Boffetta, R. Malekzadeh, A. Pourshams, Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer, Medicine (Baltimore), 95 (2016) e3922.

5. F. Janku, L.K. Johnson, D.D. Karp, J.T. Atkins, P.A. Singleton, J. Moss, Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer, Ann Oncol, 27 (2016) 2032-2038.

Study Link:https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0244285

Rush University Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.